Corpus ID: 46094669

Erythematosus Performance of Screening Tests for Cognitive Impairment in Systemic Lupus

@inproceedings{Nantes2017ErythematosusPO,
  title={Erythematosus Performance of Screening Tests for Cognitive Impairment in Systemic Lupus},
  author={Stephanie G. Nantes and Ashneet Dhaliwal and Kenneth Colosimo and Zahi Touma},
  year={2017}
}
Objective. There is a need for a cognitive function screening test that can be administered to patients with systemic lupus erythematosus (SLE) in clinic. The objectives of this study were to determine (1) prevalence of cognitive impairment (CI) in SLE by the Montreal Cognitive Assessment (MoCA), Mini Mental State Examination (MMSE), in relation to the Hopkins Verbal Learning Test–Revised (HVLT-R), and Perceived Deficits Questionnaire 5-Item (PDQ-5); and (2) associated factors with CI. Methods… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 38 REFERENCES
Screening for Cognitive Impairment in Systemic Lupus Erythematosus
TLDR
The CSI self-report questionnaire of cognitive symptoms does not reliably screen for efficiency of cognitive processing in patients with SLE, and cognitive complaints reported in the CSI are influenced by the presence of anxiety and depression. Expand
Cognitive dysfunction in SLE: development of a screening tool
TLDR
The MoCA appears to be a promising screening tool for the detection of CD in SLE both for epidemiologic studies and for routine clinical care. Expand
Cognitive impairment in systemic lupus erythematosus: a follow-up study
TLDR
Cognitive impairment seems to be a stable symptom of CNS involvement in SLE, which corresponds to the subjective complaint of intellectual difficulties and marginal performance on the MMSE, and standardized neuropsychological testing methods should be used routinely to assess SLE patients. Expand
Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus: A Controlled Study
TLDR
It is suggested that the CD found in some patients with SLE may represent the consequences of a chronic and/or inflammatory disease rather than SLE-related central nervous system damage. Expand
Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study
TLDR
Cognitive impairments were common in this group of (mild) SLE outpatients, but the level of significant subjective cognitive complaints was low even among patients with cognitive impairment, suggesting affective status may influence subjective experience of cognitive functions even more than cognitive functioning itself. Expand
Cognitive impairment in patients with systemic lupus erythematosus.
TLDR
Cognitive impairment may occur independently of clinically overt neuropsychiatric SLE and is more common in patients with active disease who are receiving corticosteroids, the results suggest. Expand
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus.
TLDR
Cognitive dysfunction is common in ambulatory SLE patients as measured by standardized tests and is a cause of distress and impaired functioning and self-reported cognitive difficulty appears to correlate with objective performance. Expand
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.
TLDR
Cognitive impairment was not associated with duration of disease, level of disease activity, or prednisone use, and neither group showed an association between incidental or major MRI abnormalities and cognitive dysfunction. Expand
Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
TLDR
The number of cognitive spheres, and especially attention, memory, and executive functions, are important factors associated with unemployment in patients with SLE. Expand
The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus
TLDR
According to the ACR nomenclature, there is a high prevalence of NP manifestations in a population-based sample of patients with SLE and most NP syndromes were classified as minor; if they were excluded, the 46% prevalence of NPSLE would be slightly less than estimated in previous studies. Expand
...
1
2
3
4
...